On the 2019 income statement, Bristol-Myers Squibb included a $156 million line item called net unrealized gain/(loss) on equity investments held. During 2019, the company maintained a port-folio of short-term investments in the current asset section of the balance sheet of $6,009 million.

INSTRUCTIONS:
Under current accounting rules, how will this $156 million gain be reflected in the financial statements?